-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on LifeStance Health Gr, Raises Price Target to $9

Benzinga·03/06/2026 15:01:59
Listen to the news
Barclays analyst Peter Warendorf maintains LifeStance Health Gr (NASDAQ:LFST) with a Overweight and raises the price target from $8 to $9.